259 related articles for article (PubMed ID: 23497265)
61. A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7.
Wang C; Gao C; Zhuang JL; Ding C; Wang Y
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2127-36. PubMed ID: 22864815
[TBL] [Abstract][Full Text] [Related]
62. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
Li J; Liang SH; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563
[TBL] [Abstract][Full Text] [Related]
63. MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells.
Cui YX; Bradbury R; Flamini V; Wu B; Jordan N; Jiang WG
Br J Cancer; 2017 Jun; 117(1):89-101. PubMed ID: 28571043
[TBL] [Abstract][Full Text] [Related]
64. Model based on GA and DNN for prediction of mRNA-Smad7 expression regulated by miRNAs in breast cancer.
Manzanarez-Ozuna E; Flores DL; Gutiérrez-López E; Cervantes D; Juárez P
Theor Biol Med Model; 2018 Dec; 15(1):24. PubMed ID: 30594253
[TBL] [Abstract][Full Text] [Related]
65. EphB6 receptor modulates micro RNA profile of breast carcinoma cells.
Bhushan L; Kandpal RP
PLoS One; 2011; 6(7):e22484. PubMed ID: 21811619
[TBL] [Abstract][Full Text] [Related]
66. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.
Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J
Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844
[TBL] [Abstract][Full Text] [Related]
67. Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.
Gong B; Hu H; Chen J; Cao S; Yu J; Xue J; Chen F; Cai Y; He H; Zhang L
Biomed Pharmacother; 2013 Sep; 67(7):629-36. PubMed ID: 23953883
[TBL] [Abstract][Full Text] [Related]
68. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
69. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
70. Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene.
Tanic M; Yanowsky K; Rodriguez-Antona C; Andrés R; Márquez-Rodas I; Osorio A; Benitez J; Martinez-Delgado B
PLoS One; 2012; 7(6):e38847. PubMed ID: 22701724
[TBL] [Abstract][Full Text] [Related]
71. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
72. Potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR.
Hurteau GJ; Spivack SD; Brock GJ
Cell Cycle; 2006 Sep; 5(17):1951-6. PubMed ID: 16929162
[TBL] [Abstract][Full Text] [Related]
73. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
74. Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer.
Tuomarila M; Luostari K; Soini Y; Kataja V; Kosma VM; Mannermaa A
PLoS One; 2014; 9(10):e109508. PubMed ID: 25329395
[TBL] [Abstract][Full Text] [Related]
75. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
[TBL] [Abstract][Full Text] [Related]
76. miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis.
Liu B; Du R; Zhou L; Xu J; Chen S; Chen J; Yang X; Liu DX; Shao ZM; Zhang L; Yu Z; Xie N; Guan JL; Liu S
Theranostics; 2018; 8(21):5801-5813. PubMed ID: 30613263
[TBL] [Abstract][Full Text] [Related]
77. Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis.
Yang Y; Xing Y; Liang C; Hu L; Xu F; Chen Y
Tumour Biol; 2015 Jul; 36(7):5571-9. PubMed ID: 25680412
[TBL] [Abstract][Full Text] [Related]
78. MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells.
Zhang H; Sun Z; Li Y; Fan D; Jiang H
Biomed Pharmacother; 2017 Apr; 88():285-292. PubMed ID: 28113080
[TBL] [Abstract][Full Text] [Related]
79. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
[TBL] [Abstract][Full Text] [Related]
80. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.
Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM
PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
